Overcoming erlotinib resistance with STAT3 inhibition in pancreatic cancer

被引：3
|
作者：
Salzberg, Matthew Philip
Merchant, Nipun B.
机构：
[1] Univ Miami, Jackson Mem Hosp, Sylvester Comprehens Canc Ctr, Miller Sch Med, Miami, FL 33136 USA
[2] Univ Miami, Med Ctr, Miami, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 04期
关键词：
D O I：
10.1200/JCO.2017.35.4_suppl.304
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
304
引用
收藏
页数：1
相关论文
共 50 条
  • [31] PTEN/STAT3 pathway in cancer-associated fibroblasts in pancreatic cancer
    Saberi, Samaneh
    Sharma, Sudarshana
    Bumbleburg, Cameron
    Lefler, Julia E.
    Ostrowski, Michael C.
    CANCER RESEARCH, 2023, 83 (07)
  • [32] PTEN/STAT3 pathway in cancer-associated fibroblasts in Pancreatic Cancer
    Saberi, Samaneh
    Bumbleburg, Cameron
    Jordan, Victoria
    Lefler, Julia E.
    Sharma, Sudarshana
    Ostrowski, Michael C.
    CANCER RESEARCH, 2024, 84 (02)
  • [33] Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer
    N D Peyser
    M Freilino
    L Wang
    Y Zeng
    H Li
    D E Johnson
    J R Grandis
    Oncogene, 2016, 35 : 1163 - 1169
  • [34] Targeting Stat3 Abrogates EGFR Inhibitor Resistance in Cancer
    Sen, Malabika
    Joyce, Sonali
    Panahandeh, Mary
    Li, Changyou
    Thomas, Sufi M.
    Maxwell, Jessica
    Wang, Lin
    Gooding, William E.
    Johnson, Daniel E.
    Grandis, Jennifer R.
    CLINICAL CANCER RESEARCH, 2012, 18 (18) : 4986 - 4996
  • [35] Preparation and characterization of lipid nanoparticle/pDNA complexes for STAT3 downregulation and overcoming chemotherapy resistance in lung cancer cells
    Kotmakci, Mustafa
    Cetintas, Vildan Bozok
    Kantarci, A. Gulten
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 525 (01) : 101 - 111
  • [36] Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer
    Peyser, N. D.
    Freilino, M.
    Wang, L.
    Zeng, Y.
    Li, H.
    Johnson, D. E.
    Grandis, J. R.
    ONCOGENE, 2016, 35 (09) : 1163 - 1169
  • [37] Inhibition of Constitutively Active Stat3 Reverses Enzalutamide Resistance in LNCaP Derivative Prostate Cancer Cells
    Liu, Chengfei
    Zhu, Yezi
    Lou, Wei
    Cui, Yuanyuan
    Evans, Christopher P.
    Gao, Allen C.
    PROSTATE, 2014, 74 (02): : 201 - 209
  • [38] INHIBITION OF CONSTITUTIVELY ACTIVE STAT3 REVERSES ENZALUTAMIDE RESISTANCE IN LNCAP DERIVATIVE PROSTATE CANCER CELLS
    Liu, Chengfei
    Zhu, Yezi
    Lou, Wei
    Cui, Yuanyuan
    Evans, Christopher P.
    Gao, Allen C.
    JOURNAL OF UROLOGY, 2014, 191 (04): : E262 - E262
  • [39] STAT3 Inhibitors: A Novel Insight for Anticancer Therapy of Pancreatic Cancer
    Li, Xin
    Jiang, Wenkai
    Dong, Shi
    Li, Wancheng
    Zhu, Weixiong
    Zhou, Wence
    BIOMOLECULES, 2022, 12 (10)
  • [40] STAT3 in tumor fibroblasts promotes an immunosuppressive microenvironment in pancreatic cancer
    Lefler, Julia E.
    MarElia-Bennett, Catherine B.
    Thies, Katie A.
    Hildreth, Blake E., III
    Sharma, Sudarshana M.
    Pitarresi, Jason R.
    Han, Lu
    Everett, Caroline
    Koivisto, Christopher
    Cuitino, Maria C.
    Timmers, Cynthia
    O'Quinn, Elizabeth
    Parrish, Melodie
    Romeo, Martin J.
    Linke, Amanda J.
    Hobbs, G. Aaron
    Leone, Gustavo
    Guttridge, Denis C.
    Zimmers, Teresa A.
    Lesinski, Gregory B.
    Ostrowski, Michael C.
    LIFE SCIENCE ALLIANCE, 2022, 5 (11)
12345